Hos patienter med tidlig reumatoid artrit (sygdomsvarighed på mindre end 3 år) (RA- forsøg V) forekom forhøjede ALAT- værdier oftere i kombinationsarmen (Humira/ methotrexat) end i methotrexat- monoterapiarmen eller Humira- monoterapiarmen.
In patients with early rheumatoid arthritis (disease duration of less than 3 years) (RA study V), elevations of ALT were more common in the combination arm (Humira / methotrexate) compared to the methotrexate monotherapy arm or the Humira monotherapy arm.